Cite

HARVARD Citation

    Scott, L. et al. (2005). Management of Skin Toxicity Related to the Use of Imatinib Mesylate (STI571, Glivec™) for Advanced Stage Gastrointestinal Stromal Tumours. Sarcoma. pp. 157-160. [Online]. 
  
Back to record